Correlation Between Change of HbA1c, Urinary Glucose Excretion and Other Factors in Patients Treated With Ipragliflozin
Phase of Trial: Phase IV
Latest Information Update: 07 Jul 2017
At a glance
- Drugs Ipragliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 03 Jul 2017 Status changed from recruiting to completed.
- 10 Jun 2017 Biomarkers information updated
- 13 Jul 2016 Status changed from not yet recruiting to recruiting.